Coronary risk factors in Kawasaki disease treated with additional gammaglobulin

Archives of Disease in Childhood

Volumn 89, Issue 8, 2004, Pages 776-780

  Miura, M ^a,b   Ohki, H ^b   Tsuchihashi, T ^b   Yamagishi, H ^b   Katada, Y ^b   Yamada, K ^b   Yamashita, Y ^b   Sugaya, A ^b   Komiyama, O ^b   Shiro, H ^b  

^a Keio Northwestern Clinic   (United States)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; PROTEINASE INHIBITOR; ULINASTATIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADRENAL CORTEX HORMONES; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; CORONARY ARTERIOSCLEROSIS; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEMALE; FEVER; GAMMA-GLOBULINS; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RISK FACTORS; TRYPSIN INHIBITORS;

EID: 3242890566     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2003.032748     Document Type: Article

References (21)

1. Burns JC, Capparelli EV, Brown JA, for the US/Canadian Kawasaki Syndrome Study Group, et al. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J 1998;17:1144-8.
2. Man RK, Silverman ED, Newman A, et al. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 2000;154:694-9.
3. Ourongpisitkul K, Soongswang J, Laohaprasitiporn D, et al. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 2003;24:145-8.
4. Sundel RP, Burns JC, Baker A, et al. Gamma globulin re-treatment in Kawasaki disease. J Pediatr 1993;123:657-9.
5. Hashino K, Ishii M, Iemura M, et al. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001;43:211-17.
6. Wallace CA, French JW, Kahn SJ, et al. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105:E78.
7. Brogan P, Bose A, Burgner D, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002;86:286-90.
8. Rowley AH, Shulman ST. Kawasaki syndrome. Pediatr Clin North Am 1999;46:313-29.
9. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
10. Beiser AS, Takahashi M, Baker AL, et al. For the US multicenter Kawasaki disease study group. A predictive instrument for coronary artery aneurysms in Kawasaki disease. Am J Cardiol 1998;81:1116-20.
11. Keren G, Lavi S, Rose V, et al. Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 1986;108:388-92.
12. Zaitsu M, Hamasaki Y, Tashiro K, et al. Ulinastatin, an elastase inhibitor, inhibits the increases mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis 2000;181:1101-9.
13. De Zorzi A, Colan SD, Gauvreau K, et al. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998;133:254-8.
14. Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr 1995;126:524-9.
15. Ayusawa M, Harada K. Appropriate use of γ-globulin for Kawasaki disease [in Japanese]. Shonika 1995;36:461-6.
16. Naoe S, Takahashi K, Masuda H, et al. Kawasaki disease with particular emphasis on arterial lesions. Acta Pathol Jpn 1991;41:785-97.
17. Kato H. Cardiovascular involvement in Kawasaki disease: evaluation and natural story. In: Shulman ST, ed. Kawasaki disease. New York: Alan R, Liss, 1987:277-86.
18. Mori M, Imagawa T, Yasui K, et al. Predictors of coronary artery lesions after intravenous γ-globulin treatment in Kawasaki disease. J Peadiatr 2000;137:177-80.
19. Miura M, Kojima Y, Satoh M, et al. Development of criteria to determine risk of coronary artery aneurysms in patients with Kawasaki disease after intravenous gamma globulin treatment [in Japanese]. Pediatr Cardiol Cardiac Surg 1997;13:12-18.
20. Newburger JW, Taubert KA, Shulman ST, et al. Summary and abstracts of the seventh international Kawasaki disease symposium. Peaiatr Res 2003;53:153-7.
21. Tse SM, Silverman ED, McCrindle BW, et al. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr 2002;140:450-5.